P009: Evaluation of HIV-infection control, risk behaviours and comorbidities among inmates in Mexico
Jaime Andrade‐Villanueva(Hospital Civil de Guadalajara), Pedro Martínez-Ayala(Hospital Civil de Guadalajara), Luz Alicia González-Hernández(Universidad de Guadalajara), Sergio Zuñiga-Quiñonez(Cornell University), David Ponce-Herrera, Raúl Soria-Rodríguez, Mara Anaís Llamas-Covarrubias(Universidad de Guadalajara)
Cited by 40
Related Papers
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|The Lancet Respiratory Medicine|2021|225
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
|The Lancet Infectious Diseases|2011|172
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Oral Manifestations Associated with HIV/AIDS Patients
|Medicina|2022|97